HUTCHMED (China) LimitedHCMNASDAQ
Loading
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -42.64% | +6.36% | +6.36% | -9.16% | -9.16% |
| Gross Profit Growth | -61.32% | +0.00% | +0.00% | -12.30% | -12.30% |
| EBITDA Growth | -118.42% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | -124.65% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -84.69% | +0.00% | +0.00% | +1663.32% | +1663.32% |
| EPS Growth | -84.38% | +0.00% | +0.00% | +1700.00% | +1700.00% |
| EPS Diluted Growth | -84.90% | +0.00% | +0.00% | +1656.76% | +1656.76% |
| Weighted Average Shares Growth | -3.05% | +39.85% | +39.85% | +1.73% | +1.73% |
| Weighted Average Shares Diluted Growth | +0.64% | +2.43% | +2.43% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -117.59% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -124.72% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +21.45% | +33.06% | +43.50% | -6.34% | -6.34% |
| Inventory Growth | -13.80% | +0.28% | +0.28% | +4.33% | -100.00% |
| Asset Growth | -2.82% | -0.44% | -0.44% | +40.85% | +40.85% |
| Book Value per Share Growth | -2.39% | -25.62% | -25.62% | +63.25% | +63.25% |
| Debt Growth | +120.67% | +4.28% | +4.28% | +13.70% | +5.47% |
| R&D Expense Growth | -34.14% | -25.45% | -25.45% | -24.42% | -24.42% |
| SG&A Expenses Growth | -15.31% | -15.11% | -15.11% | -28.00% | -28.00% |